20 Background 21 To be transmitted to vertebrate hosts via the saliva of their vectors, arthropod-borne viruses have 22 to cross several barriers in the mosquito body, including the midgut infection and escape barriers.
139
cardboard boxes protected with mosquito nets. Alternatively, ice-chilled mosquitos were injected 140 intrathoracically with twice 69 nL of viral stock with a micro-injector (Drummond, Nanoject II).
141
Mosquitoes were anesthetized on ice at various time-points after infection. They were passed through 142 a 70% ethanol bath and then in a PBS bath before being dissected in a drop of PBS under a 143 magnifying glass using tweezers. The midguts, legs and salivary glands were removed and placed in a 144 tube containing sterilized glass beads of a diameter of 0.5 mm (Dutscher) in a suitable lysis buffer.
145
Experiments were reproduced in triplicate with 5-10 mosquitoes collected at each time-point for 146 dissection.
148
RT-qPCR analysis. The mosquito organs were crushed using a tissue homogenizer (Ozyme, 149 Precellys Evolution) during twice 15 s at 10000 g. Total RNA was extracted from mosquito tissues 150 with the NucleoSpin RNA II kit (Macherey-Nagel). YFV RNA was quantified using NS3-specific were mixed with human blood to prepare a meal containing 4.10 7 PFU/mL of either YFV-17D or 227 YFV-DAK. Five to ten mosquitoes were collected every 2-3 days until 14 days post-feeding (dpf).
228
Mosquitoes were dissected to separate the midgut from legs and salivary glands. Virus production in 229 these tissues was first assayed by calculating the viral titer by plaque assays on Vero cells. Several 230 whole mosquitoes were also analyzed 20 minutes after feeding to ensure that the mosquitoes ingested 231 a similar amount of viral particles of both viral strains. Around 10 3 infectious particles of YFV-DAK 232 were detected per midguts 3 dpf ( Fig. 1A ). Viral titers remained high in midguts until 14 dpf. YFV-233 10 DAK infectious particles were present in legs as early as 5 dpf and in salivary glands as early as 7 dpf 234 ( Fig. 1A ). This replication pattern is comparable to that of South American and Africain YFV isolates 235 in the strain Ae. aegypti AE-GOI [33] . Midgut of mosquitoes infection with YFV-17D produced 1 to 2 236 log less infectious particles than YFV-DAK at 3 dpf ( Fig. 1B) . Infectious particles were detected in a 
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Viral replication was assessed in the midguts, legs and salivary glands by measuring viral RNA 242 quantity over-time by RT-qPCR. Total RNA was also extracted from several whole mosquitoes the 243 same day of the feeding to insure that they had ingested similar amount of infectious particles from 244 both viral strains. Around 10 7 copies of viral RNA were detected in midguts of mosquitoes infected 245 with YFV-DAK since 3 days (Fig. 1C) . The viral RNA copy number per midgut remained high until 246 14 dpf, indicating that viral replication had already reached a plateau at early stage of infection ( Fig. 
247
1C). In agreement with titration assays (Fig. 1A) , YFV-DAK RNA was detected in legs and salivary 248 glands of mosquitoes around 7 dpf. The quantity of viral RNA detected in these secondary organs 249 increased over time to reach on average 10 7 copies RNA in legs and 10 6 copies in salivary glands at 250 14 dpf (Fig. 1C ). Around 5.10 5 copies of YFV-17D RNA was detected in 2 out of 5 midguts of blood-251 feed mosquitoes at 3 dpf ( Fig. 1D ). At 12 dpf, around 10 7 copies of YFV-17D RNA was detected in 4 252 out of 8 mosquitoes, which is 10 time less than in YFV-DAK infected moquitoes. YFV-17D RNA was 253 found in legs of 2 mosquitoes among the 46 blood-fed mosquitoes collected during 14 days. No virus 254 was dectected in the salivary glands of these 46 mosquitoes (Fig. 1D ). Thus, in agreement with our 255 titration assays ( Fig. 1B ) and with previous studies performed with Rexville strains of Ae. aegypti [34-256 36], YFV-17D disseminated poorly in the strain Paea. The RT-qPCR analysis also revealed that the 257 vaccine strain replicated less efficiently than YFV-DAK in its vector.
258
The pourcentage of mosquitoes that were positive for viral RNA among the mosquitoes that had 259 taken blood was calculated based on RT-qPCR data obtained from 3 independent experiments (Fig.
260
1E). Significantly less midguts were postivive for YFV-17D RNA than YFV-DAK RNA at days 7 and 261 11 14 post-feeding, suggesting that the midgut infection barrier restrict the replication of the vaccine 262 strain. Viral dissemination was defined by the presence of viral RNA in the legs of mosquitoes whose 263 midguts were infected ( Fig. 1F ). YFV-DAK had disseminated in around 40% of infected mosquitoes 264 at 7 dpf and in around 90% of mosquitoes at 14 dpf. At this time, YFV-17D had disseminated in 265 around 10% of them ( Fig. 1F ). YFV-DAK dissemination rates are consistent with the ones reported 266 for the YFV-Asibi strain [36] or clinical isolates from Peru [35] in Rexville mosquitoes. YFV-DAK
267
RNA was detected in salivary glands of approximately 75% of mosquitoes whose legs were infected, 268 revealing that the virus was efficiently transmitted (Fig. 1G ). By constrast, no viral tranmission was 269 observed for YFV-17D.
270
To investigate the replication ability of the two viral strains further, the presence of viral antigens 271 in pooled midguts and salivary glands of mosquitoes fed on blood containing 4.10 7 PFU/mL of either 272 YFV-17D or YFV-DAK was analyzed by Western blots at days 7 and 14 post-feeding using 273 antibodies against Env and NS1. The Env protein was detected at both time-points in the midgut of 274 mosquitoes infected with the strain YFV-DAK, in a majority form of around 45 kDa and a minor form 275 of around 35 kDa ( Fig. 2A ). The Env protein was not detected in the salivary glands 7 days after the 276 blood meal but was present as a 45 kDa form 14 days after the blood meal ( Fig. 2A ). These data are in 277 good agreement with the titration and RT-qPCR data presented in Figure 1 . Like the Env protein, the 278 NS1 protein was detected in the midguts of mosquitoes infected with the YFV-DAK strain at both 7 279 and 14 dpf ( Fig. 2A ). In midguts, NS1 was detected at the expected size of 45 kDa, but also as heavier 280 forms of around 80 kDa. These forms could represent NS1-2A, a polyprotein precursor consisting of 281 NS1 and a portion of NS2A. This NS1-2A form was previously reported in human SW-13 cells 282 infected with YFV-17D [23] and maybe generated by alternative cleavage sites in the NS2A region 283 upstream from the cleavage site generating the N-terminus of NS2B. Alternatively, they could 284 represent glycosylated versions of NS1 monomer or dimer. NS1 was also detected in the salivary 285 glands of mosquitoes infected with YFV-DAK for 14 days ( Fig. 2A) . No or very little signal was 286 detected by the anti-NS1 or anti-Env antibodies in organs of mosquitoes infected with YFV-17D ( Fig.   287 2A). In order to ensure that the antibodies directed against the NS1 and Env proteins recognize YFV-
288
17D proteins, control experiments were performed with the Ae. aegypti Aag2 cells infected for 24 or 289 12 48 hours at an MOI of 0.1 with both viral strains. Both proteins were well detected in cells infected for 290 48 hrs, independently of the viral strain used (Fig. 2B) . Thus, absence of detection of YFV-17D Env 291 and NS1 proteins in the mosquito organs at 7 and 14 dpf is not due to poor recognition of the viral 292 antigens, nor the antibodies used, but reflects a low-level replication. These data confirm our titration 293 and RT-qPCR analysis (Fig. 1) . Of note, the YFV-DAK Env was detected as 2 forms in Aag2 cells 294 infected for 48 hours while the YFV-17D Env was detected as a unique form. No YFV-17D proteins 295 were detected at 24 hours post-infection, suggesting that the replication of the vaccine strain is less 296 efficient in Aag2 cells than the one of YFV-DAK.
297
Finally, to confirm RT-qPCR and Western blot data, immunofluorescence analyses were 298 performed on miguts of mosquitoes fed since 7 days using antibodies againt the viral protein NS4B.
299
YFV-DAK antigens were evenly distributed in foci over the entire epithelium at this time (Fig. 3A) .
300
By contrast, YFV-17D antigens were found in one or two localized foci in infected midguts. In an 301 attempt to assess this unevenly distribution of YFV-17D replication sites, the midgut of mosquitoes 302 infected with both viral strains for 3 or 7 days were cut longitudinally into two equal parts. The 303 presence of viral RNA was determined by RT-qPCR analysis performed on individual half midguts 304 ( Fig. 3B ). Among 18 mosquitoes that injested blood containing YFV-17D, 3 half midguts were 305 positive for YFV-17D RNA at day 3 post-infection and only 2 at day 7 post-infection. This is in 306 agreement for our previous results (Fig. 1E ). Among these five positive midguts, only one contained 307 YFV-17D RNA in both sections (Fig. 3B ). As expected based on previous results (Fig. 1E) , it was 308 easier to obtain midguts positive for YFV-DAK. Twelve out of the 15 midguts that were positive for 309 YFV-DAK RNA contained viral RNA in both sections. These experiments revealed that YFV-17D 310 replication in Ae. aegypti midgut is more confined that the one of YFV-DAK.
311
Together, these data show that, by contrast the clinical isolate YFV-DAK, the vaccine strain 312 replicated poorly in, and disseminated poorly from Ae. aegypti midgut. To assess whether YFV-17D could infect Ae. aegypti when delivered via a non-oral route, 317 mosquitoes were inoculated intra-thoracically with 2,5.10 4 PFU of YFV-17D or YFV-DAK. This 318 amount of infectious particles injected corresponds to around 10 times less PFU than when mosquitoes 319 are taking around 5 µL blood meal containing 4.10 7 PFU/mL. The presence of viral RNA was 320 analyzed by RT-qPCR 10 days after injection. Mosquitoes infected via a blood meal served as 321 controls. Several whole mosquitoes were also analyzed 20 minutes after feeding or injection to ensure 322 that a similar amount of viral particles of both viral strains were delivered in mosquitoes. In good 323 agreement with our previous experiments (Fig. 1) , around 35% of midguts (8 out 22) were positive for 324 YFV-17D RNA, whereas 81% (18 out 22) were positive for YFV-DAK RNA 10 dpf (Fig. 4A ).
325
Moreover, significantly less viral RNA (around 10 times) was found in YFV-17D-infected midguts as 326 compared to DAK-infected midguts (Fig. 4A ). YFV-DAK RNA was detected in legs and salivary 327 glands of around 50% of these mosquitoes. By contrast, YFV-17D was detected in the legs of a unique 328 mosquito out of 22 and was not detected in salivary glands (Fig. 4A) , confirming the inability of the 329 vaccine strain to spread to secondary organs and to be transmitted when orally delivered. When the 330 midgut barriers were bypassed by injecting Ae. aegypti mosquitoes in the thorax, 100% of midguts 331 were positive for both viral strains and similar amounts of YFV-17D and YFV-DAK RNA were 332 detected in this organ, indicating that both viral strains successfully replicated in midgut associated 333 tissue when bypassing the lumen (Fig. 4B ). All legs and salivary glands are positive for YFV-17D and 334 YFV-DAK RNA (Fig. 4B) , revealing that the two viruses were efficiently infecting secondary tissues 335 once the midgut was bypassed. Of note, significantly more (around 10 times) YFV-DAK RNA was 336 detected in salivary glands than YFV-17D RNA (Fig. 4B ), suggesting that YFV-17D is sensitive to the 337 salivary gland infection barrier.
338
To ensure that viral RNA detected in secondary organs of injected mosquitoes represented 339 replicative RNA and not input viral RNA, UV-treated viral RNA was also injected into the thorax of 340 several mosquitoes. A signal, slightly above the detection threshold, was detected in two organs out of 341 39 tested (Fig. 4B) . These data confirm the ability of YFV-17D to replicate as efficiently as YFV-
342
DAK in midgut and secondary organs when mosquitoes were inoculated intra-thoracically. 
357
To determine a consensus sequence of the two viral strains and to analyze their variability, we 358 performed next generation sequencing (NGS) analysis of the two viral stocks. Coverage depth for 359 these alignments was between 200 and 300. The comparison of the two consensus sequences 360 identified 316 synonymous mutations ( Fig. 5A and 5B , blue bars) and 56 non-synonymous ones (Fig.   361 5B, red bars). These differences were scattered along the genome. Some of these non-synonymous 362 mutations, as well as the 8 mutations present in the 3' untranslated region (UTR) of the genome, could 363 have functional consequences (Fig. 5B) . Figure 5C 368 as compared to DAK genome is surprising since a recent study showed that the vaccine strains YFV-
369
17D and YFV-FNV contained fewer variants than their respective parental strains [39] . However, 370 these observations do not inform on the general variability of the genomes since they concern only a 371 small number of nucleotides.
15
We then estimated the diversity of each nucleotide of the viral genomes using the Simpson 1-D
373
[29] and Shannon's entropy indexes [28] (Fig. 5D) . A Wilcoxon test showed that the YFV-DAK strain 374 has a significantly greater global diversity than that of YFV-17D (Table 2) (p = 1.77e-03 and U = 56 375 957 560, p = 6.92e-08, and U = 56 180 896, respectively for the two indices). When comparing the 376 diversity of each open reading frame using the two indexes, three genes of the YFV-DAK strain, 377 coding for the C, Env and NS1 proteins, had a significantly higher diversity than their YFV-17D 378 counterparts (dark green in Table 2 ). These analyzes suggest that these three proteins are major 379 determinants of YFV-DAK diversity. As expected, when these three genes were subtracted from the 380 analysis, the two viral genomes were no longer different in terms of genetic diversity ( 
Discussion 393
Previous studies have shown, using titration assays on organs of the Rex-D strain of Ae. aegypti, 394 that YFV-17D infects the midgut, but does not spread to secondary organs [21, 36] . Our RT-qPCR, 395 immunofluorescence and titration analyzes revealed that the YFV-17D also replicates in the midgut of 396 the Paea strain of Ae. aegypti. However, its replication was significantly less effective than the one of 397 the clinical isolate YFV-DAK. Among the YFV-17D viruses that replicated in the midgut, less than 398 10% managed to reach secondary organs. None of these viruses did spread to the salivary glands.
399
Thus, our data suggest that the YFV-17D strain is not only sensitive to the midgut escape barrier, but 400 also to the midgut infection barrier when orally delivered. When injected into the thorax of 401 mosquitoes, YFV-17D replicated in midgut tissues as efficiently as YFV-DAK. These data suggest 402 that the restriction of YFV-17D replication in the midgut occur at the level of epithelial cells. Our RT-403 qPCR analyzes suggest that the major restriction occurs at a stage prior to viral RNA production.
404
Several mechanisms, not mutually exclusive, could explain this restriction.
405
First, the restriction could occur during viral entry in midgut epithelial cells. Flavivirus entry 406 mechanisms are poorly described in mosquito cells. Neither attachment factor(s) nor entry receptor(s)
407
are identified yet. As in mammalian cells, the domain III of Env is involved in attachment and entry of 408 the virus [40] . Thus, it is conceivable that YFV-17D Env would have a lower affinity for cell entry 409 factors than YFV-DAK Env. Our NGS analysis revealed that the consensus sequence of the two Env 410 proteins differs from 69 mutations, including 12 non-synonymous mutations. Seven of these non-411 synonymous mutations lie within the domain III. In addition, the YFV-DAK Env gene is more diverse 412 than the YFV-17D Env gene. Finally, in Aag2 cells infected for 48 hours, we detected two forms of 413 YFV-DAK Env under non-reducing conditions and a single form of YFV-17D Env. These differences 414 may reflect a different conformation and may explain a different affinity for a cell entry receptor. In 415 agreement with this hypothesis, when domain III of the Env gene of a YFV virus able to disseminate 416 was replaced by domain III of the Env gene of YFV-17D, the dissemination of the chimeric virus was 417 strongly inhibited, suggesting an important role in Domain III in this process [21] . These results, 418 however, may be the consequence of chimerization, as it is known that flavivirus chimeras replicate 419 less efficiently than parental viruses [41] . We have recently shown that the YFV-Asibi enters a panel of human cells by canonical endocytosis mechanisms involving clathrin, while YFV-17D enters cells 421 in a clathrin-independent manner [12] . We have shown that the 12 mutations differentiating YFV-
422
Asibi Env from YFV-17D Env are responsible for the differential internalization process. Based on 423 these data, we hypothesized that YFV-17D and YFV-Asibi use different cell receptors [12] . It is 424 therefore possible that the YFV-17D and YFV-DAK strains use different receptors in mosquito cells 425 and that the receptor used by YFV-17D is poorly expressed at the apical surface of midgut epithelial 426 cells, as compared to the one used by the clinical strain. Alternatively, the glycosylation status of the 427 Env protein could play a role in the differential entry abilities of the two strains. 
433
However, it is unlikely that this site is functional because it is located in the hydrophobic carboxy-434 terminal domain and is therefore inserted into the endoplasmic reticulum membrane. The absence of 435 an accessible N-glycosylation site in YFV-DAK Env therefore indicates that such motif is probably 436 not necessary for replication and dissemination in mosquitoes. We therefore believe that mutations in 437 Env, rather than its glycosylation status, are involved in vector competence.
438
Another mechanism that could explain the low replication of YFV-17D in the midgut of 439 mosquitoes is its inability to escape the antiviral mechanisms in epithelial cells. The RNA interference 440 pathway (RNAi) is a major antiviral defense initiated by the recognition of viral replication 441 intermediates by the Dicer-2 protein [46] . This pathway inhibits the replication of DENV and ZIKV 442 viruses in the midgut and salivary glands of mosquitoes [47] [48] [49] . Interestingly, Myles and colleagues 443 recently showed that the YFV C protein counteracts the RNA interference pathway in Ae. aegypti by 444 protecting double-stranded viral RNA from Dicer-2-induced cleavage [50] . No amino acid sequence 445 responsible for this effect has been identified. Our NGS analysis revealed that the consensus sequence 446 of the C gene of our two strains of interest differ by 10 mutations, including a non-synonymous one.
447
In addition, the YFV-DAK C gene exhibited more diversity than the one of YFV-17D. This unique 448 18 mutation and/or these differences in C protein diversity could modulate their RNA interference 449 suppression activities. It is unfortunate that Myles and colleagues [50] did not provide information on 450 the viral strain they used.
451
The NS1 YFV-DAK gene is the third gene that has significantly greater diversity than its YFV-452 17D counterpart. Flavivirus NS1 protein is a highly conserved glycoprotein that associates as a dimer 453 with cell membranes and is secreted into the extracellular medium as an hexamer [51] . It has recently 454 been shown that the NS1 proteins secreted by cells infected by DENV and JEV enhance viral 455 replication in their vectors by allowing them to escape two important antiviral mechanisms: the 456 production of reactive species of oxygen (ROS) and the JAK / STAT pathway [52] . One can envisage 457 that, like the NS1 proteins of DENV and JEV, YFV-DAK NS1 protein could be a potent suppressor of 458 these two antiviral strategies. The NS1 protein of YFV-DAK could also be more expressed and/or 459 secreted than the one of YFV-17D.
460
Further studies will be needed to identify the molecular mechanism (s) responsible for the low 461 replication and dissemination of the YFV-17D vaccine strain in Aedes mosquito. These studies are 462 essential to better understand the interactions between viruses and their vectors and can also contribute 
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Mosquitoes were orally infected with 4.10 7 PFU/mL of YFV-DAK (A and C) or YFV-17D (B and D).
